JA
Jayanthi Abraham
About Jayanthi Abraham
Data last updated:
Jayanthi Abraham has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Schiefflin Institute Of Health-Research And Leprosy Centre. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Schiefflin Institute Of Health-Research And Leprosy Centre at ₹16.58 Cr (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Schiefflin Institute Of Health-Research And Leprosy Centre U93090TN1977NPL007299 | Director | 19 Dec 2015 | 1977 | ₹16.58 Cr (FY 2019) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jayanthi Abraham
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jayanthi Abraham
Jayanthi Abraham has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Schiefflin Institute Of Health-Research And Leprosy Centre. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Schiefflin Institute Of Health-Research And Leprosy Centre at ₹16.58 Cr (FY 2019).
Jayanthi Abraham is associated with 1 company as Director, including Schiefflin Institute Of Health-Research And Leprosy Centre (₹16.58 Cr).
Jayanthi Abraham has expertise in Healthcare.
Jayanthi Abraham has 10 years in corporate governance.
By reported revenue, the largest current company of Jayanthi Abraham is Schiefflin Institute Of Health-Research And Leprosy Centre, with revenue of ₹16.58 Cr (FY 2019).
Jayanthi Abraham currently holds positions at 1 company: Schiefflin Institute Of Health-Research And Leprosy Centre (₹16.58 Cr).